Amsbio offers a wide selection of over 325,000 pre-characterized chemical compounds to support your drug screening applications for discovery and development.

From individual inhibitors, agonists and natural products to ready-to-screen compound libraries, these cost-effective, high-quality reagents are perfect for both academic and industrial research.

Whether you are studying apoptosis, autophagy, cell cycle regulation, immunology, or signaling cascades our portfolio of over 20,000 small molecule inhibitors and agonists offer excellent membrane permeability, high chemical stability, and versatility in both in vitro and in vivo investigations.

Our carefully curated compound libraries are rigorously validated and widely used by pharmaceutical and biotech high throughput screening groups. Choose from over 800 compound libraries including focused bioactive compounds, natural products, fragments, and diversity sets, each designed to explore specific biological targets or chemical space.

Supplied with strict quality assurance data (HNMR, HPLC, GC) to confirm structural accuracy and purity, we offer over 16,000 natural products, such as flavonoids, alkaloids, terpenoids, coumarins, and saponins for use in oncology, infectious disease, neurobiology, and metabolic research.

In addition, Amsbio offers a range of PROTAC (Proteolysis Targeting Chimeras) molecules. PROTACs are heterobifunctional molecules that degrade target proteins by hijacking the ubiquitin–proteasome system. PROTACs often exhibit enhanced target engagement compared to traditional small molecule inhibitors due to their ability to induce proximity-driven ubiquitination of the target protein.

Available in a range of different pack sizes to best suit your drug discovery needs – this comprehensive range of pre-characterized compounds are readily searchable by CAS number, name, and product code.

About AMS Biotechnology (Amsbio)

Now part of the Europa Biosite group of companies, AMS Biotechnology (Amsbio) is recognized as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products, and services for R&D in the medical, nutrition, cosmetics, and energy industries. Amsbio has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion, and proliferation. This expertise in cell culture and the ECM allows Amsbio to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics. For drug discovery research, Amsbio offers assays, recombinant proteins, and cell lines. Drawing upon a huge and comprehensive biorepository, Amsbio is widely recognized as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cells and cell therapy applications. This includes GMP cryopreservation technology, and high-quality solutions for viral delivery.

Recent news from Amsbio